Angiotensin-converting enzyme inhibitors and atherosclerosis: Relevance of animal models to human disease

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages s30-s32

  Fennessy, Paul A ^a   Campbell, Julie H ^a   Mendelsohn, Frederick A O ^b   Campbell, Gordon R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitor; Atherosclerosis; Bradykinin; Hoel40; Losartan; Perindopril; Regression

Indexed keywords

BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; HUMAN; LIPID METABOLISM; NONHUMAN; RABBIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HUMANS; INDOLES; PERINDOPRIL; RABBITS;

EID: 0029868756     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03038.x     Document Type: Article

References (14)

1. Kowala MC, Grove RI, Aberg G. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Atherosclerosis 1994; 108: 61-72.
2. Miyazaki M, Song K, Ishii K, Okunishi H, Ikeno A, Hosoki K. Vascular angiotensin converting enzyme in cholesterol-fed monkeys and anti-atherosclerotic property of an angiotensin converting enzyme inhibitor, alacepril. In: Third International Symposium on ACE Inhibition, Amsterdam 1993. Gardiner-Caldwell Communications Ltd, Macclesfield, UK. 1993; Abstract 7A:4.
3. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in Cynpmolgus monkeys. J. Cardiovasc. Pharmacol. 1990; 15 (Suppl. 5): 565-72.
4. Jacobssen LS, Persson K, Aberg G, Andersson RGG, Karlberg BE, Olsson AG. Antiatherosclerotic effects of the angiotensinconverting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J. Cardiovasc. Pharmacol. 1994; 24: 670-7.
5. Overturf M, Sybers H, Schaper J, Taegtmayer H. Hypertension and atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1986:59:283-99.
6. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe Heritable Hyperlipidemic rabbit. Hypertension 1990:15: 327-31.
7. Stary HC, Blankenhorn DH, Chandler AB et al. A definition of the intima of human arteries and of its atherosclerotic-prone regions: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Special Report. Circulation 1992; 85: 391-405.
8. Manderson JA, Mosse PRL, Safstrom JA, Young SB, Campbell GR. Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype. Anerioscler. Thromb. 1989; 9:289-98.
9. Fennessy PA, Campbell JH, Campbell GR. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. Atherosclerosis 1994; 106: 29-41.
10. Fennessy PA, Campbell JH, Campbell GR. An ACE inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit. Clin. Sci. 1994; 87: 685-91.
11. Caplice NM, Fennessy PA, Manderson JA, Campbell GR, Campbell JH. Rabbit models of atherosclerosis and restenosis. In: Woodford FP, Davignon J, Sniderman A (eds). Atherosclerosis X. Elsevier, Amsterdam. 1995; pp 114-20.
12. Chai SY, Mendelsohn FAO, Paxinos G. Angiotensin-converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 1987; 20: 615-27.
13. McKinley MJ, Alien AM, Clevers J, Denton DA, Mendelsohn FAO. Autoradiographic localization of angiotensin receptors in the sheep brain. Brain Res. 1986; 375: 373-6.
14. Lonn EM, Yusuf S, Jha P et al. Emerging role of angiotensin converting-enzyme inhibitors in cardiac and vascular protection. Circulation 1994; 90: 2056-69.